Polypill cuts CVD risk by one-third

Largest trial to date shows four in one pill effective for primary prevention: study
assortment of pills

A polypill combining four cardiovascular drugs cut the risk of major cardiovascular events by a third over five years, a Lancet study finds. 

The study looked at the effectiveness of the four-in-one pill in primary and secondary prevention of CVD in rural Iran.